Patents by Inventor Birgit Jung

Birgit Jung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for identifying substances which positively influence inflammatory conditions
    Publication number: 20030103965
    Abstract: The present invention relates to NHR-proteins involved in inflammatory processes and the modulation of the function of such NHR-protein in order to positively influence inflammatory diseases.
    Type: Application
    Filed: August 5, 2002
    Publication date: June 5, 2003
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Birgit Jung, Norbert Kraut, Stefan Mueller
  • Novel arylglycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
    Publication number: 20030092704
    Abstract: The invention relates to new arylglycinamide derivatives of general formula I 1
    Type: Application
    Filed: September 5, 2002
    Publication date: May 15, 2003
    Applicant: Boehringer Ingelheim Pharma KG
    Inventors: Franz Esser, Gerd Schnorrenberg, Kurt Schromm, Horst Dollinger, Birgit Jung, Georg Speck
  • Arylglycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
    Patent number: 6498162
    Abstract: The invention relates to new arylglycinamide derivatives of general formula I and the pharmaceutically acceptable salts thereof, wherein R1 and R2 together with the N to which they are bound form a ring of the formula in which R3, R4, R5, Ar, R6, R7, R8, R9, R10, R11, r, s and t have the meanings given in the specification and the preparation and use thereof. The new compounds are valuable neurokinin (tachykinin) antagonists.
    Type: Grant
    Filed: November 1, 2000
    Date of Patent: December 24, 2002
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Franz Esser, Gerd Schnorrenberg, Kurt Schromm, Horst Dollinger, Birgit Jung, Georg Speck
  • Bicyclic heterocycles, pharmaceutical compositions containing them, their use, and processes for preparing them
    Publication number: 20020177601
    Abstract: A compound of formula (I) 1
    Type: Application
    Filed: August 23, 2001
    Publication date: November 28, 2002
    Inventors: Frank Himmelsbach, Elke Langkopf, Stefan Blech, Birgit Jung, Thomas Metz, Flavio Solca
  • Quinazoline derivatives and phamaceutical compositions containing them
    Publication number: 20020173509
    Abstract: A compound of general formula I 1
    Type: Application
    Filed: December 17, 2001
    Publication date: November 21, 2002
    Inventors: Frank Himmelsbach, Elke Langkopf, Stefan Blech, Birgit Jung, Anke Baum, Flavio Solca
  • Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
    Publication number: 20020169180
    Abstract: The present invention relates to bicyclic heterocycles of general formula 1
    Type: Application
    Filed: December 10, 2001
    Publication date: November 14, 2002
    Inventors: Frank Himmelsbach, Elke Langkopf, Thomas Metz, Flavio Solca, Birgit Jung, Anke Baum
  • Method for identifying compounds which positively influence inflammatory conditions
    Publication number: 20020160438
    Abstract: The present invention relates to kinases involved in inflammatory processes and the modulation of the function of such kinases in order to positively influence inflammatory diseases.
    Type: Application
    Filed: December 21, 2001
    Publication date: October 31, 2002
    Inventors: Birgit Jung, Stefan Mueller, Norbert Kraut
  • Methods for identifying substances for treating inflammatory conditions
    Publication number: 20020150958
    Abstract: The present invention relates to proteins involved in inflammatory processes and the modulation of the function of such a protein in order to positively influence inflammatory diseases.
    Type: Application
    Filed: December 21, 2001
    Publication date: October 17, 2002
    Inventors: Birgit Jung, Stefan Mueller, Norbert Kraut
  • Neurokinin antagonists
    Publication number: 20020147219
    Abstract: The invention relates to new compounds of formula I 1
    Type: Application
    Filed: October 16, 2001
    Publication date: October 10, 2002
    Inventors: Horst Dollinger, Franz Esser, Birgit Jung, Kurt Schromm, Georg Speck
  • Use of an LTB4 antagonist for the treatment or prevention of diseases caused by increased expression of mucin genes
    Publication number: 20020137792
    Abstract: Medicaments and pharmaceutical kits comprising an LTB4 antagonist of formula (I) 1
    Type: Application
    Filed: January 16, 2002
    Publication date: September 26, 2002
    Inventors: Ralf Anderskewitz, Christopher J. Montague Meade, Franz Birke, Hans Michael Jennewein, Birgit Jung
  • Methods for identifying substances for treating inflammatory conditions
    Publication number: 20020137099
    Abstract: The present invention relates to UDD-proteins involved in inflammatory processes and the modulation of the function of such a UDD-protein in order to positively influence inflammatory diseases.
    Type: Application
    Filed: December 21, 2001
    Publication date: September 26, 2002
    Inventors: Birgit Jung, Stefan Mueller, Norbert Kraut
  • Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases
    Publication number: 20020119494
    Abstract: The present invention relates to substances which modulate receptors involved in inflammatory processes and whose modulated functions positively influence inflammatory diseases.
    Type: Application
    Filed: August 31, 2001
    Publication date: August 29, 2002
    Inventors: Birgit Jung, Norbert Kraut, Stefan Mueller, Barbara Kistler, Peter Seither, Karsten Quast, Andreas Weith
  • Aminoquinazolines which inhibit signal transduction mediated by tyrosine kinases
    Publication number: 20020115675
    Abstract: Compounds of the formula 1
    Type: Application
    Filed: August 22, 2001
    Publication date: August 22, 2002
    Inventors: Frank Himmelsbach, Elke Langkopf, Birgit Jung, Stefan Blech, Flavio Solca
  • Neurokinin antagonists
    Publication number: 20020115666
    Abstract: The invention relates to new compounds of formula I 1
    Type: Application
    Filed: October 16, 2001
    Publication date: August 22, 2002
    Inventors: Horst Dollinger, Franz Esser, Birgit Jung, Gerd Schnorrenberg, Kurt Schromm, Georg Speck
  • Tricyclic nitrogen heterocycles as PDE IV inhibitors
    Patent number: 6417190
    Abstract: The invention relates to the use of tricyclic nitrogen heterocycles of general formula I as pharmaceutical compositions with an inhibitory effect on PDE IV, wherein the groups R1, R2 and R3 have the meanings given in the specification and claims.
    Type: Grant
    Filed: December 10, 1999
    Date of Patent: July 9, 2002
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Matthias Hoffmann, Birgit Jung, Ulrike Kuefner-Muehl, Christopher John Montague Meade
  • New arylglycinamide derivatives, processes for the manufacture thereof and pharmaceutical compositions containing these compounds
    Publication number: 20020086863
    Abstract: The invention relates to new arylglycinamide derivatives of general formula I 1
    Type: Application
    Filed: October 5, 2001
    Publication date: July 4, 2002
    Applicant: Boehringer Ingelheim KG.
    Inventors: Gerd Schnorrenberg, Horst Dollinger, Franz Esser, Hans Briem, Birgit Jung, Georg Speck
  • Method of treating depression with arylglycinamide derivatives
    Patent number: 6413959
    Abstract: The invention relates to new arylglycinamide derivatives of general formula I and the pharmaceutically acceptable salts thereof, wherein R1 and R2 together with the N to which they are bound form a ring of the formula wherein p is 2 or 3 and X denotes oxygen, N(CH2)nR6 or CR7R8, and R3, R4, R5, R6, R7, R8, Ar and n have the meanings given in the specification, and the preparation and use thereof. The new compounds are valuable neurokinin (tachykinin)-antagonists.
    Type: Grant
    Filed: October 5, 2001
    Date of Patent: July 2, 2002
    Assignee: Boehringer Ingelheim KG
    Inventors: Gerd Schnorrenberg, Horst Dollinger, Franz Esser, Hans Briem, Birgit Jung, Georg Speck
  • Aminoquinazolines which inhibit signal transduction mediated by tyrosine kinases
    Publication number: 20020082271
    Abstract: Compounds of the formula 1
    Type: Application
    Filed: August 22, 2001
    Publication date: June 27, 2002
    Inventors: Frank Himmelsbach, Elke Langkopf, Birgit Jung, Stefan Blech, Flavio Solca
  • Aminoquinazolines which inhibit signal transduction mediated by tyrosine kinases
    Publication number: 20020082270
    Abstract: Compounds of the formula 1
    Type: Application
    Filed: August 22, 2001
    Publication date: June 27, 2002
    Inventors: Frank Himmelsbach, Elke Langkopf, Birgit Jung, Stefan Blech, Flavio Solca
  • Bicyclic heterocycles, pharmaceutical compositions containing them, their use, and processes for preparing them
    Publication number: 20020082420
    Abstract: A compound of formula (I) 1
    Type: Application
    Filed: August 21, 2001
    Publication date: June 27, 2002
    Inventors: Frank Himmelsbach, Elke Langkopf, Stefan Blech, Birgit Jung, Thomas Metz